High expression of EGFR predicts poor survival in patients with resected T3 stage gastric adenocarcinoma and promotes cancer cell survival

Epidermal growth factor receptor (EGFR) is an essential regulator and biomarker of several types of cancer. However, the association between its expression and prognosis in patients with resected T3 stage gastric adenocarcinoma (RT3-GA) remains to be determined. In total, 683 patients with resectabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Daiyong, Wang, Bing, Wang, Ruohan, Zhang, Zaizhong, Lin, Youdong, Huang, Guoliang, Lin, Songbin, Jiang, Yifan, Wang, Wenyuan, Wang, Lie, Huang, Qiaojia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431275/
https://www.ncbi.nlm.nih.gov/pubmed/28521408
http://dx.doi.org/10.3892/ol.2017.5827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431275/
https://www.ncbi.nlm.nih.gov/pubmed/28521408
http://dx.doi.org/10.3892/ol.2017.5827

Ejemplares similares